PD-L1 Status in Refractory Lymphomas

Targeted immunotherapy based on PD-1/PD-L1 suppression has revolutionized the treatment of various solid tumors. A remarkable improvement has also been observed in the treatment of patients with refractory/relapsing classical Hodgkin lymphoma (cHL). We investigated PD-L1 status in a variety of treat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS One
Hlavní autoři: Vranic, Semir, Ghosh, Nilanjan, Kimbrough, Jeffery, Bilalovic, Nurija, Bender, Ryan, Arguello, David, Veloso, Yvonne, Dizdarevic, Aida, Gatalica, Zoran
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2016
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5115714/
https://ncbi.nlm.nih.gov/pubmed/27861596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0166266
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky